Share, Send, or Save

Our Ethical Standards

Ethics and Compliance at Alexion

Alexion's Board of Directors and Executive Committee have established an Executive-level Ethics and Compliance program, led by our Chief Compliance Officer, Compliance Committee and Compliance Team. Alexion's Compliance program is tailored to meet the standards set forth by the Office of Inspector General (OIG) for the U.S. Department of Health and Human Services in its 2003 Compliance Program Guidance for Pharmaceutical Manufacturers.

Alexion's Compliance Program incorporates the seven fundamental elements of an effective compliance program as defined by the OIG:

Alexion's
Ethics and Compliance
Helpline

Alexion is committed to quality, ethics, integrity and compliance. Our helpline provides a mechanism for asking questions or reporting potential concerns.
Compliance Helpline Portal: www.Alexion.EthicsPoint.com
Compliance Helpline (U.S.A): 1-866-294-8685

      Access Additional Helpline Numbers
 

1

Designated Compliance Officer and Compliance committee

 

2

Implementing written policies and procedures

 

3

Effective training and education

 

4

Open lines of communication

 

5

Internal auditing and monitoring

 

6

Enforcement of standards through disciplinary guidelines

 

7

Prompt response to detected problems through corrective actions

 

Anti-Corruption and Anti-Bribery

Alexion has a zero tolerance policy towards bribery and corruption. We comply with the anti-corruption laws of every country in which we operate, including the U.S. Foreign Corrupt Practices Act and the U.K. Bribery Act.

Vendor Code of Conduct

Alexion and its subsidiaries are committed to conducting business in an ethical, legal, and socially responsible manner. We expect our vendors to share this commitment.

Download the Vendor Code of Conduct
 

Transparency Requirements

Alexion will make public any disclosures necessary to comply with transparency laws or regulations applicable to pharmaceutical manufacturers, including, but not limited to, National Physician Payment Transparency Program (“Open Payments”) in the United States and the Loi Bertrand Act (“Sunshine Act”) in France. These regulations have mandated increased transparency in interactions between healthcare providers and companies manufacturing health care products and/or medical devices. The intention of these requirements is to eliminate potential conflicts of interest in the interactions between these companies and healthcare professionals. To comply with these regulations, Alexion reports certain payments or other transfers of value made in the course of our professional interactions with healthcare professionals and healthcare organizations where applicable.

California Compliance Declaration

Alexion is committed to establishing and maintaining a comprehensive and effective compliance program in accordance with California SB 1765 (California Business & Professions Code 119400, 119402), and the Office of Inspector General, U.S. Department of Health and Human Services, "Compliance Program Guidance for Pharmaceutical Manufacturers."

California Compliance Declaration